Clinical TrialID 7185
Carbon-11 Labeled Sarcosine in Prostate Cancer
NCT02462447
Prostate Cancer
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 7185
- Evidence Id
- 7185
- Core Evidence Id
- 7185
- Source Clinical Trial Id
- 7174
- Herb2 Clinical Trial Id
- HBCT007174
- Nct Id
- NCT02462447
- Title
- Carbon-11 Labeled Sarcosine in Prostate Cancer
- Status
- Completed
- Phase
- Study Result
- No
- Study Condition
- Prostate Cancer
- Study Type
- Observational
- Study Design
- Observational Model: |Time Perspective: p
- Intervention
- DRUG: 11C-sarcosine|DRUG: 11C-choline
- Intervention Allocation
- Intervention Model
- Intervention Mask
- Intervention Purpose
- Gender
- Male
- Age
- Adult, Older_Adult
- Enrollment
- 20
- Outcome Measure
- Evaluation of biodistribution of 11C-sarcosine in prostate cancer patients, One Month|Evaluation of radiation dosimetry of 11C-sarcosine in healthy volunteers, One Month
- Sponsor Collaborator
- University of Michigan|National Institutes of Health (NIH)|National Cancer Institute (NCI)
- Funded By
- OTHER
- Location
- University of Michigan Health Systems, Ann Arbor, Michigan, 48109, United States
- Other Id
- HUM00091201|R21CA191052-01
- Start Date
- 2015-06
- Primary Completion Date
- 2017-02-08
- Completion Date
- 2017-02-08
- First Posted
- 2015-06-04
- Results First Posted
- Last Update Posted
- 2017-11-09
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT02462447
- Title Cn
- Title En
- Carbon-11 Labeled Sarcosine in Prostate Cancer
- Bilingual Status
- semi_complete